- Home
- BNR vs WVVI Comparison
BNR vs WVVI Comparison
Compare BNR & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- WVVI
- Stock Information
- Founded
- BNR 2014
- WVVI 1983
- Country
- BNR China
- WVVI United States
- Employees
- BNR N/A
- WVVI N/A
- Industry
- BNR Medical Specialities
- WVVI Beverages (Production/Distribution)
- Sector
- BNR Health Care
- WVVI Consumer Staples
- Exchange
- BNR Nasdaq
- WVVI Nasdaq
- Market Cap
- BNR 29.1M
- WVVI 28.2M
- IPO Year
- BNR 2020
- WVVI N/A
- Fundamental
- Price
- BNR $3.86
- WVVI $5.58
- Analyst Decision
- BNR
- WVVI
- Analyst Count
- BNR 0
- WVVI 0
- Target Price
- BNR N/A
- WVVI N/A
- AVG Volume (30 Days)
- BNR 35.7K
- WVVI 25.7K
- Earning Date
- BNR 08-21-2025
- WVVI 08-12-2025
- Dividend Yield
- BNR N/A
- WVVI N/A
- EPS Growth
- BNR N/A
- WVVI N/A
- EPS
- BNR N/A
- WVVI N/A
- Revenue
- BNR $72,112,038.00
- WVVI $38,520,945.00
- Revenue This Year
- BNR $136.32
- WVVI N/A
- Revenue Next Year
- BNR N/A
- WVVI N/A
- P/E Ratio
- BNR N/A
- WVVI N/A
- Revenue Growth
- BNR 0.53
- WVVI N/A
- 52 Week Low
- BNR $2.18
- WVVI $3.17
- 52 Week High
- BNR $7.90
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- BNR 62.38
- WVVI 48.00
- Support Level
- BNR $3.06
- WVVI $5.50
- Resistance Level
- BNR $3.50
- WVVI $5.86
- Average True Range (ATR)
- BNR 0.23
- WVVI 0.52
- MACD
- BNR 0.03
- WVVI 0.04
- Stochastic Oscillator
- BNR 87.26
- WVVI 38.43
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.